An Analysis of Blood Utilization for Stem Cell Transplant Patients in a Tertiary Care Hospital.
- Author:
Natasha ALI
1
Author Information
- Publication Type:Original Article
- Keywords: C:T ratio; Blood utilisation; Stem cell transplant; PRBCs
- MeSH: Adult; Anemia, Aplastic; Benchmarking; beta-Thalassemia; Blood Transfusion; Bone Marrow; Developing Countries; Diagnosis; Erythrocytes; Female; Humans; Leukemia; Lymphoma; Male; Multiple Myeloma; Outcome Assessment (Health Care); Retrospective Studies; Stem Cells*; Tertiary Healthcare*
- From:International Journal of Stem Cells 2017;10(1):114-118
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND AND OBJECTIVE: Haematopoietic stem cell transplant is a potentially curative treatment option in various benign and malignant haematological diseases. Patients undergoing stem cell transplant procedure require blood transfusion on a daily basis. Currently, there is paucity of data from developing countries on transfusion practices. This audit was undertaken to determine the consumption of packed red blood cells (PRBCs) transfusion in the bone marrow transplant unit of the Aga Khan University Hospital. SUBJECTS AND METHODS: A retrospective audit was conducted for packed red cell transfusion ordering practice over a period from June 2014~June 2015. All consecutive patients, admitted for stem cell transplant procedure for various underlying diseases were included. Outcome measures used in this study were (i) cross match to transfusion (C: T) ratio and (ii) transfusion trigger. RESULTS: During the study period, n=25 patients underwent haematopoietic stem cell transplant. There were n=19 males and n=6 females. One patient was less than 15 years of age while rests were adults. Median age±SD was 26.5±14.5 years (12~54 years). The underlying diagnosis included Aplastic anemia (n=8), Thalassemia major (n=3), Multiple Myeloma (n=4), Acute leukemia (n=5), Hodgkin’s lymphoma (n=4), PRCA (n=1). Grand total consumption of PRBCs during the study period was 204 while 258 products were crossmatch. The C:T ratio was 1.26. The transfusion trigger was Hb level of less than 8 gms/dl. CONCLUSION: The results of our BMT unit indicate that the C:T ratio and transfusion trigger is comparable to the international benchmark.
